Jeff Cislini, General Counsel at Revolution Medicines, Inc. (RVMD), sold 3,738 shares at $45.82 ($171K) on 2025-09-16, disclosed to the SEC on 2025-09-18.
Scheduled sale ($171k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.82 | 1,869 | $86K | 50.0% |
| 2 | $45.82 | 1,869 | $86K | 50.0% |
| Total | $45.82 avg | 3,738 | $171K | 100% |
| Filing → |
| RVMD | SELL | 2026-08-25 | $11.9M | — | Filing → |
| RVMD | SELL | 2026-06-18 | $337K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $470K | — | Filing → |